Debevoise & Plimpton LLP is advising Konica Minolta in the sale of its subsidiary Invicro to Calyx, a portfolio company of CapVest and leading technology-enabled provider. For more information, please see the company’s press release.

Invicro is a next-generation quantitative imaging biomarker company focused on accelerating the discovery and development of life-changing medicines.

The Debevoise team is led by M&A partner Andrew Bab and includes partner Jennifer Chu, counsel Sergio Torres, associates Michael Cederblom, Andrew Lee, Hannah Levine, Matthew Ryan, Elina Sigal, Erick Wong and Jason Zhang and law clerks Emily Espinel and Stephen Mattes, executive compensation and employee benefits partner Jonathan Lewis, tax partner Michael Bolotin and associate David Simpser, intellectual property partner Henry Lebowitz, counsel Tigist Kassahun and associate Melody Godbolt, FDA regulatory partner Paul Rubin and Melissa Runsten, healthcare regulatory counsel Kim Le, antitrust partners Ted Hassi and Timothy McIver, counsel Kyra Bromley and associate Megan MacDonald, CFIUS regulatory partner Ezra Borut and counsel Robert Dura, litigation associates Isabelle Glimcher, Leah Martin and Emily Morgan and environmental counsel Stuart Hammer.